1. |
Peggy N, Brubaker L. Urinary incontinence in women. Lancet, 2006, 367(9504): 57-67.
|
2. |
Hampel C, Wienhold D, Benken N, et al. Prevalence and natural history of female incontinence. Eur Urol, 1997, 32 Suppl 2: 3-12.
|
3. |
Bump RC, Norton PA. Epidemiology and natural history of pelvic fioor dysfunction. Obstet Gynecol Clin North Am, 1998, 25(4): 723-746.
|
4. |
Strasser H, Berjukow S, Marksteiner R, et al. Stem cell therapy for urinary stress incontinence. Exp Gerontol, 2004, 39(9): 1259-1265..
|
5. |
韩平, 解慧琪, 罗静聪, 等. 细胞治疗临床应用新进展. 中国修复重建外科杂志, 2008, 22(2): 221-227.
|
6. |
Bhatia NN, Ho MH. Stem cell therapy for urinary incontinence and pelvic floor disorders: a novel approach. Curr Opin Obstet Gynecol, 2004, 16(5): 397-398..
|
7. |
Corcos J, Loutochin O, Campeau L, et al. Bone marrow mesenchymal stromal cell therapy for External urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourol Urodyn, 2011, 30(3): 447-455.
|
8. |
Kim SO, Na HS, Kwon D, et al. Bone-marrow-derived Mese nc hymal stem cell transplantation enhances closing pressure and leak point pressure in a female urinary incontinence rat model. Urol Int, 2011, 86(1): 110-116.
|
9. |
Kinebuchi Y, Aizawa N, Imamura T, et al. Autologous bone-marrow-derived mesenchymal stem cell transplantation into injured rat urethral sphincter. Int J Urol, 2010, 17(4): 359-368.
|
10. |
Imamura T, Ishizuka O, Kinebuchi Y, et al. Implantation of autologous bone-marrow-derived cells Reconstructs functional urethral sphincters in rabbits. Tissue Eng Part a, 2011, 17(7-8): 1069-1081.
|
11. |
Strasser H, Marksteiner R, Margreiter E, et al. Transurethral ultrasound guided injection of clonally cultured autologous myoblasts and fibroblasts: experimental results. J Urol, 2003, 169: 39.
|
12. |
Lee JY, Cannon TW, Pruchnic R, et al. The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2003, 14(1): 31-37.
|
13. |
Gimble JM. Adipose tissue-derived therapeutics. Expert Opin Biol Ther, 2003, 3(5): 705-713.
|
14. |
Wu G, Zheng X, Jiang Z, et al. Induced differentiation of adipose-derived stromal cells into myoblasts. J Huazhong Univ Sci Technol, 2010, 30(3): 285-290.
|
15. |
Forraz N, Mcguckin CP. The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Prolif, 2011, 44(Suppl 1): 60-69.
|
16. |
Chermansky CJ, Tarin T, Kwon DD, et al. Intraurethral muscle-derived cell injections increase leak point pressure in a rat model of intrinsic sphincter deficiency. Urology, 2004, 63(4): 780-785.
|
17. |
Lim JJ, Jang JB, Kim JY, et al. Human umbilical cord blood mononuclear cell transplantation in rats with intrinsic sphin cter deficiency. J Korean Med Sci, 2010, 25(5): 663-670.
|
18. |
Carr LK, Steele D, Steele S, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2008, 19(6): 881-883.
|
19. |
Lee CN, Jang JB, Kim JY, et al. Human cord blood stem cell therapy for treatment of stress urinary incontinence. J Korean Med Sci, 2010, 25(6): 813-816.
|
20. |
Atala A, Cima LG, Kim W, et al. Injectable alginate seeded with chondrocytes as a potential treatment for vesicoureteral reflux. J Urol, 1993, 150(2 Pt 2): 745-747..
|
21. |
Atala A, Kim W, Paige KT, et al. Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension. J Urol, 1994, 152(2 Pt 2): 641-643.
|
22. |
Bent AE, Tutrone RT, McLennan MT, et al. Treatment of intrinsic sphincter deficiency using autologous ear chond rocytes as a bulking agent. Neurourol Urodyn, 2001, 20(2): 157-165.
|
23. |
Vandenburgh H, Del TM, Shansky J, et al. Tissue-engineered skeletal muscle organoids for reversible gene therapy. Hum Gene Ther, 1996, 7(17): 2195-2200.
|
24. |
Chancellor MB, Yokoyama T, Tirney S, et al. Preliminary results of myoblast injection into the urethra and bladder wall: a possible method for the treatment of stress urinary incontin ence and impaired detrusor contractility. Neurourol Urodyn, 2000, 19(3): 279-287.
|
25. |
Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 1995, 18(12): 1417-1426.
|
26. |
Strasser H, Berjukow S, Marksteiner R, et al. Stem cell therapy for urinary stress incontinence. Exp Gerontol, 2004, 39(9): 1259-1265.
|
27. |
Fu Q, Song XF, G, Liao GL, et al. Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence. Urology, 2010, 75(2): 718-723.
|
28. |
Lee OK, Kuo TK, Chen WM, et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood, 2004, 103(5): 1669-1675.
|
29. |
Sarugaser R, Lickorish D, Baksh D, et al. Human umbilical cord perivascular(hucpv)cells: a source of mesenchymal progenitors. Stem Cells, 2005, 23(2): 220-229.
|
30. |
Kaviani A, Perry TE, Dzakovic A, et al. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg, 2001, 36(11): 1662-1665.
|
31. |
Bilic G, Zeisberger SM, Mallik AS, et al. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant, 2008, 17(8): 955-968.
|
32. |
Portmann-Lanz PC, Andreina S, Huber A, et al. Placental mesenchymal stem cells as potential autologous graft for pre-and perinatal neuroregeneration. Am J Obstet Gynecol, 2006, 194(3): 664-673.
|